News
Jigyasa Grover shares what worked and what she'd change about the résumés that landed her roles at Meta and X.
CVS Caremark has selected Novo Nordisk’s Wegovy as the preferred GLP-1 medication for its largest commercial template formularies, effective July 1. In March, Novo Nordisk launched NovoCare Pharmacy ...
Starting July 1, Wegovy will become the preferred GLP-1 for obesity treatment on CVS Caremark’s largest commercial template ...
CVS Health raised its full-year profit forecast on Thursday and said it plans to exit the market for Obamacare health ...
CEO David Joyner highlighted a strong start to 2025, reporting adjusted EPS of $2.25 and adjusted operating income of $4.6 billion. Full-year 2025 adjusted EPS guidance was raised to $6 to $6.20. CVS ...
Effective July 1, 2025, CVS Caremark will place Wegovy injection 2.4 mg as preferred on its commercial template formularies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results